Blue light therapy for hyperbilirubinemia may alter skin microbiome
Blue light phototherapy for hyperbilirubinemia may be associated with short-term changes to the skin and gut microbiome, as well as inflammatory signaling, according to a study published in Pediatric Dermatology.
Based on the limited long-term clinical trials available, the researchers concluded that there is no evidence of a relationship between blue light phototherapy for neonatal hyperbilirubinemia, an underlying cause of jaundice, and an increased risk for future atopic disease and skin cancer. However, the lack of available data highlights a need for future longitudinal studies, according